ReviewFrontiers in immunology2022
Prospects for NK-based immunotherapy of chronic HBV infection.
Xiaomeng Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Xiaomeng Jin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.